A medical technology entrepreneur who is working with the University of Notre Dame IDEA Center is preparing for the commercial launch of a pillow that can improve oxygen flow for patients who struggle with emphysema and COPD. ... Read More
New data shows Indiana continues to lead the nation in life science products exports, including pharmaceuticals, medical devices, and agbiosciences. BioCrossroads, Indiana’s initiative to grow the life sciences sector, says $13 billion of the products were shipped out of the Hoosier State in 2022, compared to $12.7 billion the previous year.... Read More
A team of Purdue University scientists has received a $2.5 million grant from the National Institutes of Health to examine the role of lipid droplets in muscle stem cell function for both people and livestock. Their results could provide insight to recovery in muscle-related disease and injury in humans, and animal growth to enhance meat production.... Read More
Eli Lilly and Co. on Wednesday announced it is cutting prices by 70% for some of its most commonly prescribed insulins. The Indianapolis-based drug maker also said it will expand a program that caps patient out-of-pocket costs at $35 or less a month.... Read More
West Lafayette-based pharma-technology startup Novilytic LLC has made its commercial product launch and announced plans to expand to a second location in the Indianapolis area, while also growing its staff. The young company developed technology that provides pharmaceutical companies with a real-time alert if a batch of drugs under development is contaminated.... Read More
Warsaw-based OrthoPediatrics Corp. is reporting full-year net income of $1.3 million in 2022, compared to a loss of $16 million the previous year. The medical device maker said Tuesday it also saw record annual revenue of $122 million last year.... Read More
A European animal nutrition company has acquired a minority stake in Fishers-based BiomEdit. Nutreco is not disclosing the amount of its financial investment but said it is part of BiomEdit's $40 million Series A funding round announced last year.... Read More
Technology that measures blood hemoglobin through a smartphone has earned top honors for a Purdue University biomedical engineering researcher. Professor Young Kim, founder and chief science officer of digital health startup HemaChrome, won phase 1 of National Institutes of Health competition.... Read More
Patty Martin, president and CEO of BioCrossroads since 2019, said Tuesday she plans to step down from the organization in April to examine opportunities in the private sector. The not-for-profit organization did not name a successor.... Read More
West Lafayette-based Inotiv is reporting a fiscal first quarter net loss of $86.9 million. CEO Robert Leasure said the pharmaceutical testing company had some unexpected challenges during the quarter that are being addressed.... Read More
An Indiana medical device company that is developing electrical nerve stimulation therapies for children is planning to go public this spring, with a proposed $15 million initial public offering. Neuraxis said it will use the proceeds to ramp up...... Read More
The FDA has approved a treatment from Indianapolis-based Eli Lilly and Co. for adult patients with relapsed or refractory mantle cell lymphoma. Jaypirca was approved under the FDA's Accelerated Approval pathway based on results from a Phase 1/2 study.... Read More
This year is slated to be a big one for Indianapolis-based Eli Lilly and Co. as the pharmaceutical giant plans to release four new medicines to the public, with even more in the pipeline. CEO Dave Ricks said the momentum was created by tailwinds in 2022.... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says it will contribute more $1 million towards the purchase and installation of medical-grade refrigeration units in 17 impoverished nations. Lilly is partnering with Direct Relief, a global humanitarian aid organization, to improve “last mile” delivery of essential medications in low-income regions of the world.... Read More
Could West Lafayette lay claim to the cure for malaria in the coming years? It’s entirely possible; the potential breakthrough treatment is on the doorstep of Phase 3 clinical trials after it was shown to be 100% effective in a Phase 2 trial. Perhaps making the scenario even more likely is the scientist who discovered […]... Read More
A beloved family pet that battled cancer led its owners to Purdue University veterinarians, who extended the dog’s life by more than a year. It prompted the successful Brown County entrepreneurs to recently gift the college $10 million... Read More
A uniquely Indiana business deal involving NBA basketball, a major ag producer and farmers is putting a new crop in the spotlight at one of the biggest Hoosier venues: Gainbridge Fieldhouse. The partnership between the Indiana Soybean Alliance (ISA) and Pacers Sports & Entertainment Inc. means fried food at all Gainbridge Fieldhouse events will be […]... Read More
Music therapy is hitting a high note in central Indiana. Two new efforts—one focused on patients and the other on training tomorrow’s clinicians—are expected to give more Hoosiers access to the healing power of music.... Read More
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) said Tuesday it plans to invest another $450 million at a factory in North Carolina that makes diabetes medicines and devices.... Read More
Indiana’s healthcare and life sciences sector, often hailed as a key driver of the state’s economy, landed a record $619.8 million in venture funding last year, a hefty increase over the previous record, set a year earlier.... Read More
